+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID05041530

Study of REBUILD Bioabsorbable Device for Closing the Abdomen After Cancer Surgery via Laparotomy

Led by AbSolutions Med Inc. · Updated on 2022-12-27

30

Participants Needed

2

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the REBUILD Bioabsorbable device to assess its safety and performance in patients undergoing open, elective, intent-to-cure laparotomy procedures for cancer treatment. This prospective, non-randomized, multi-center study aims to generate descriptive data on how REBUILD distributes suture tension in abdominal wall closures in oncology patients. The study focuses on device-related adverse events and the integrity of the abdominal wall over one year. Participants will have their abdominal wall closed using the REBUILD Bioabsorbable device combined with a surgeons choice of suture during their standard oncologic laparotomy procedure. The study is single-arm, meaning all participants receive the same investigational device without comparison to other treatments. The devices performance will be monitored over a 12-month period after surgery. During the study, participants will be followed up to assess safety and effectiveness. The primary safety outcome is the occurrence of device-related adverse events within 12 months. The primary performance outcome is evaluated through clinical abdominal examinations and, if available, CT scans within 12 months to confirm the abdominal walls integrity. Participants are expected to comply with follow-up visits and study requirements for the full duration of the study.

CONDITIONS

Brief Title

Abdominal Wall Closure After Laparotomy in Oncologic Surgery

Research Team

D

Daniel Jacobs, MD

K

Kathryn Kelley, BSN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here